First-line treatment of advanced ALK-positive non-small-cell lung cancer

Shipra Gandhi,1 Hongbin Chen,2 Yujie Zhao,2 Grace K Dy2 1Department of Internal Medicine, State University of New York, 2Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY, USA Abstract: Non-small-cell lung cancer (NSCLC) is one of the leading causes of cancer deaths, both within th...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Gandhi S, Chen H, Zhao Y, Dy GK
Format: article
Langue:EN
Publié: Dove Medical Press 2015
Sujets:
Accès en ligne:https://doaj.org/article/67a00b2a4f4c4ec59b7bd979698c07ea
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!